Top

Quality of Life Research

Gepubliceerd in:

17-10-2018

Sex differences in predictors of illness intrusiveness in persons with multiple sclerosis

Auteurs: Lindsay O. Neto, Elizabeth S. Gromisch, Jessica Sloan, Tuula Tyry, Frederick W. Foley

Gepubliceerd in: Quality of Life Research | Uitgave 2/2019

Abstract

Purpose

Multiple sclerosis (MS) is a complex, chronic disease that can have debilitating effects on daily activities and well-being, compromising health-related quality of life. One underlying determinant of quality of life (QOL) is perceived illness intrusiveness, which examines the disruptiveness of the condition and/or its related treatment on engagement in interest and activities, in turn affecting psychological functioning. There is evidence that persons with MS (PwMS) have higher level of illness intrusiveness compared to those with other chronic conditions; however, limited research exists on differences by sex. This study aimed to explore these possible differences between men and women, hypothesizing that men with MS will have overall higher illness intrusiveness (lower QOL) when compared to women with MS.

Methods

A total of 922 PwMS were primarily recruited through the North American Research Committee on MS Registry. The participants completed a one-time anonymous online survey. Illness intrusiveness was measured using the Illness Intrusiveness Ratings Scale (IIRS) total score and three subscales. Independent t-tests determined differences in demographics, disease characteristics, and IIRS outcomes. Hierarchical regressions were then used to further assess whether sex was a significant predictor of illness intrusiveness.

Results

Men exhibited greater overall, intimacy, and relationship and personal development-related perceived illness intrusiveness. However, sex was only a significant predictor of the Intimacy IIRS subscale after accounting for age, disability, and depression.

Conclusions

These findings highlight the intrusiveness of MS on intimacy and sexual functioning, particularly among men. Potential clinical implications and future directions are discussed.

vorige artikel Determinants of satisfaction with life and self-esteem in women with breast cancer

volgende artikel Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiency

Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000). Multiple sclerosis. The New England Journal of Medicine, 343(13), 938–952. https://doi.org/10.1056/NEJM200009283431307.CrossRefPubMed

Zwibel, H. L., & Smrtka, J. (2011). Improving quality of life in multiple sclerosis: An unmet need. American Journal of Managed Care, 17(Suppl 5 Improving), 139–145.

Trojano, M., Lucchese, G., Graziano, G., Taylor, B. V., Simpson, S. Jr., Lepore, V., et al. (2012). Geographical variations in sex ratio trends over time in multiple sclerosis. PLoS ONE, 7(10), e48078. https://doi.org/10.1371/journal.pone.0048078.CrossRefPubMedPubMedCentral

Green, G., & Todd, J. (2008). ‘Restricting choices and limiting independence’: Social and economic impact of multiple sclerosis upon households by level of disability. Chronic Illness, 4(3), 160–172. https://doi.org/10.1177/1742395307087457.CrossRefPubMed

Aymerich, M., Guillamon, I., & Jovell, A. J. (2009). Health-related quality of life assessment in people with multiple sclerosis and their family caregivers. A multicenter study in Catalonia (Southern Europe). Patient Preference and Adherence, 3, 311–321.CrossRef

Brola, W., Sobolewski, P., Fudala, M., Flaga, S., Jantarski, K., Ryglewicz, D., et al. (2016). Self-reported quality of life in multiple sclerosis patients: Preliminary results based on the Polish MS Registry. Patient Preference and Adherence, 10, 1647–1656. https://doi.org/10.2147/PPA.S109520.CrossRefPubMedPubMedCentral

Rezapour, A., Almasian Kia, A., Goodarzi, S., Hasoumi, M., Motlagh, N., S., & Vahedi, S. (2017). The impact of disease characteristics on multiple sclerosis patients’ quality of life. Epidemiology and Health, 39, e2017008. https://doi.org/10.4178/epih.e2017008.CrossRefPubMedPubMedCentral

Benito-Leon, J., Mitchell, A. J., Rivera-Navarro, J., & Morales-Gonzalez, J. M. (2013). Impaired health-related quality of life predicts progression of disability in multiple sclerosis. European Journal of Neurology, 20(1), 79–86. https://doi.org/10.1111/j.1468-1331.2012.03792.x.CrossRefPubMed

Patti, F. P. A. (2010). Quality of life in patients affected by multiple sclerosis: A systemic review. New York: Springer.

10.

Amato, M. P., Ponziani, G., Rossi, F., Liedl, C. L., Stefanile, C., & Rossi, L. (2001). Quality of life in multiple sclerosis: The impact of depression, fatigue and disability. Multiple Sclerosis Journal, 7(5), 340–344. https://doi.org/10.1177/135245850100700511.CrossRefPubMed

11.

Kalia, L. V., & O’Connor, P. W. (2005). Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Multiple Sclerosis Journal, 11(3), 322–327. https://doi.org/10.1191/1352458505ms1168oa.CrossRefPubMed

12.

Nortvedt, M. W., Riise, T., Myhr, K. M., Landtblom, A. M., Bakke, A., & Nyland, H. I. (2001). Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis Journal, 7(4), 231–235. https://doi.org/10.1177/135245850100700404.CrossRefPubMed

13.

Baumstarck, K., Pelletier, J., Boucekine, M., Auquier, P., & MusiQo, L. s. g (2015). Predictors of quality of life in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study. Revue Neurologique (Paris), 171(2), 173–180. https://doi.org/10.1016/j.neurol.2014.09.005.CrossRef

14.

Fernandez, O., Baumstarck-Barrau, K., Simeoni, M. C., Auquier, P., & MusiQoL (2011). Patient characteristics and determinants of quality of life in an international population with multiple sclerosis: Assessment using the MusiQoL and SF-36 questionnaires. Multiple Sclerosis Journal, 17(10), 1238–1249. https://doi.org/10.1177/1352458511407951.CrossRefPubMed

15.

Miller, A., & Dishon, S. (2006). Health-related quality of life in multiple sclerosis: The impact of disability, gender and employment status. Quality of Life Research, 15(2), 259–271. https://doi.org/10.1007/s11136-005-0891-6.CrossRefPubMed

16.

Bergamaschi, R. (2007). Prognostic factors in multiple sclerosis. International Review of Neurobiology, 79, 423–447. https://doi.org/10.1016/S0074-7742(07)79019-0.CrossRefPubMed

17.

Bove, R., McHenry, A., Hellwig, K., Houtchens, M., Razaz, N., Smyth, P., et al. (2016). Multiple sclerosis in men: Management considerations. Journal of Neurology, 263(7), 1263–1273. https://doi.org/10.1007/s00415-015-8005-z.CrossRefPubMed

18.

Casetta, I., Riise, T., Wamme Nortvedt, M., Economou, N. T., De Gennaro, R., Fazio, P., et al. (2009). Gender differences in health-related quality of life in multiple sclerosis. Multiple Sclerosis Journal, 15(11), 1339–1346. https://doi.org/10.1177/1352458509107016.CrossRefPubMed

19.

Costa, D. C., Marques Sa, M. J., & Calheiros, J. M. (2013). Social characteristics and quality of life of Portuguese multiple sclerosis patients. Neurology and Therapy, 2(1–2), 43–56. https://doi.org/10.1007/s40120-013-0011-4.CrossRefPubMedPubMedCentral

20.

Karakiewicz, B., Stala, C., Grochans, E., Rotter, I., Mroczek, B., Zaremba-Pechmann, L., et al. (2010). Assessment of the impact of some sociodemographic factors on the quality of life of patients with multiple sclerosis. Annales Academiae Medicae Stetinensis, 56(3), 107–112.PubMed

21.

Lex, H., Weisenbach, S., Sloane, J., Syed, S., Rasky, E., & Freidl, W. (2018). Social-emotional aspects of quality of life in multiple sclerosis. Psychology, Health & Medicine, 23(4), 411–423. https://doi.org/10.1080/13548506.2017.1385818.CrossRef

22.

Turpin, K. V., Carroll, L. J., Cassidy, J. D., & Hader, W. J. (2007). Deterioration in the health-related quality of life of persons with multiple sclerosis: The possible warning signs. Multiple Sclerosis Journal, 13(8), 1038–1045. https://doi.org/10.1177/1352458507078393.CrossRefPubMed

23.

Pfennings, L., Cohen, L., Ader, H., Polman, C., Lankhorst, G., Smits, R., et al. (1999). Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life. Journal of Neurology, 246(7), 587–591.CrossRef

24.

Shawaryn, M. A., Schiaffino, K. M., LaRocca, N. G., & Johnston, M. V. (2002). Determinants of health-related quality of life in multiple sderosis: The role of illness intrusiveness. Multiple Sclerosis Journal, 8(4), 310–318. https://doi.org/10.1191/1352458502ms808oa.CrossRefPubMed

25.

Devins, G. (2010). Using the illness intrusiveness ratings scale to understand health-related quality of life in chronic disease. Journal of Psychosomatic Research, 68, 591–602.CrossRef

26.

Franche, R. L., Abbey, S., Irvine, J., Shnek, Z. M., Grace, S. L., Devins, G. M., et al. (2004). Sex differences in predictors of illness intrusiveness 1 year after a cardiac event. Journal of Psychosomatic Research, 56(1), 125–132. https://doi.org/10.1016/S0022-3999(03)00505-1.CrossRefPubMed

27.

Mullins, A. J., Gamwell, K. L., Sharkey, C. M., Bakula, D. M., Tackett, A. P., Suorsa, K. I., et al. (2017). Illness uncertainty and illness intrusiveness as predictors of depressive and anxious symptomology in college students with chronic illnesses. Journal of American College Health, 65(5), 352–360. https://doi.org/10.1080/07448481.2017.1312415.CrossRefPubMed

28.

Devins, G., Seland, T., Klein, G., Edworthy, S., & Sary, M. (1993). Stability and determinants of psychosocial well-being in multiple sclerosis. Rehabilitation Psychology, 38(1), 11.CrossRef

29.

Snyder, S., Foley, F. W., Farrell, E., Beier, M., & Zemon, V. (2013). Psychological and physical predictors of illness intrusiveness in patients with multiple sclerosis. Journal of the Neurological Sciences, 332(1–2), 41–44. https://doi.org/10.1016/j.jns.2013.06.009.CrossRefPubMed

30.

Bouchard, V., Duquette, P., & Mayo, N. E. (2017). Path to illness intrusiveness: What symptoms affect the life of people living with multiple sclerosis? Archives of Physical Medicine and Rehabilitation, 98(7), 1357–1365. https://doi.org/10.1016/j.apmr.2017.03.012.CrossRefPubMed

31.

Devins, G. M., Edworthy, S. M., Seland, T. P., Klein, G. M., Paul, L. C., & Mandin, H. (1993). Differences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. The Journal of Nervous and Mental Disease, 181(6), 377–381.CrossRef

32.

Honarmand, K., & Feinstein, A. (2009). Validation of the hospital anxiety and depression scale for use with multiple sclerosis patients. Multiple Sclerosis Journal, 15(12), 1518–1524. https://doi.org/10.1177/1352458509347150.CrossRefPubMed

33.

Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.CrossRef

34.

Marrie, R. A., Zhang, L., Lix, L. M., Graff, L. A., Walker, J. R., Fisk, J. D., et al. (2018). The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis. Multiple Sclerosis and Related Disorders, 20, 9–15. https://doi.org/10.1016/j.msard.2017.12.007.CrossRefPubMed

35.

Hohol, M. J., Orav, E. J., & Weiner, H. L. (1995). Disease steps in multiple sclerosis: A simple approach to evaluate disease progression. Neurology, 45(2), 251–255.CrossRef

36.

Hohol, M. J., Orav, E. J., & Weiner, H. L. (1999). Disease steps in multiple sclerosis: A longitudinal study comparing disease steps and EDSS to evaluate disease progression. Multiple Sclerosis Journal, 5(5), 349–354. https://doi.org/10.1177/135245859900500508.CrossRefPubMed

37.

Marrie, R. A., & Goldman, M. (2007). Validity of performance scales for disability assessment in multiple sclerosis. Multiple Sclerosis Journal, 13(9), 1176–1182. https://doi.org/10.1177/1352458507078388.CrossRefPubMed

38.

Learmonth, Y. C., Motl, R. W., Sandroff, B. M., Pula, J. H., & Cadavid, D. (2013). Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis. BMC Neurology, 13, 37. https://doi.org/10.1186/1471-2377-13-37.CrossRefPubMedPubMedCentral

39.

Devins, G. M. (2010). Using the illness intrusiveness ratings scale to understand health-related quality of life in chronic disease. Journal of Psychosomatic Research, 68(6), 591–602. https://doi.org/10.1016/j.jpsychores.2009.05.006.CrossRef

40.

Field, A. (2009). Discovering statistics using SPSS. Thousand Oaks: SAGE.

41.

Calabro, R. S., De Luca, R., Conti-Nibali, V., Reitano, S., Leo, A., & Bramanti, P. (2014). Sexual dysfunction in male patients with multiple sclerosis: A need for counseling! International Journal of Neuroscience, 124(8), 547–557. https://doi.org/10.3109/00207454.2013.865183.CrossRefPubMed

42.

Celik, D. B., Poyraz, E. C., Bingol, A., Idiman, E., Ozakbas, S., & Kaya, D. (2013). Sexual dysfunction in multiple sclerosis: Gender differences. Journal of the Neurological Sciences, 324(1–2), 17–20. https://doi.org/10.1016/j.jns.2012.08.019.CrossRefPubMed

43.

Marck, C. H., Jelinek, P. L., Weiland, T. J., Hocking, J. S., De Livera, A. M., Taylor, K. L., et al. (2016). Sexual function in multiple sclerosis and associations with demographic, disease and lifestyle characteristics: An international cross-sectional study. BMC Neurology, 16(1), 210. https://doi.org/10.1186/s12883-016-0735-8.CrossRefPubMedPubMedCentral

44.

McCabe, M. P. (2002). Relationship functioning and sexuality among people with multiple sclerosis. The Journal of Sex Research, 39(4), 302–309. https://doi.org/10.1080/00224490209552154.CrossRefPubMed

45.

Zorzon, M., Zivadinov, R., Bosco, A., Bragadin, L. M., Moretti, R., Bonfigli, L., et al. (1999). Sexual dysfunction in multiple sclerosis: A case-control study. I. Frequency and comparison of groups. Multiple Sclerosis Journal, 5(6), 418–427. https://doi.org/10.1177/135245859900500i609.CrossRefPubMed

46.

Foley, F. W., Zemon, V., Campagnolo, D., Marrie, R. A., Cutter, G., Tyry, T., et al. (2013). The multiple sclerosis intimacy and sexuality questionnaire: Re-validation and development of a 15-item version with a large US sample. Multiple Sclerosis Journal, 19(9), 1197–1203. https://doi.org/10.1177/1352458512471876.CrossRefPubMed

47.

Schairer, L. C., Foley, F. W., Zemon, V., Tyry, T., Campagnolo, D., Marrie, R. A., et al. (2014). The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis. Multiple Sclerosis Journal, 20(5), 610–616. https://doi.org/10.1177/1352458513503598.CrossRefPubMed

48.

Vitkova, M., Rosenberger, J., Krokavcova, M., Szilasiova, J., Gdovinova, Z., Groothoff, J. W., et al. (2014). Health-related quality of life in multiple sclerosis patients with bladder, bowel and sexual dysfunction. Disability and Rehabilitation, 36(12), 987–992. https://doi.org/10.3109/09638288.2013.825332.CrossRefPubMed

49.

Tepavcevic, D. K., Kostic, J., Basuroski, I. D., Stojsavljevic, N., Pekmezovic, T., & Drulovic, J. (2008). The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis. Multiple Sclerosis Journal, 14(8), 1131–1136. https://doi.org/10.1177/1352458508093619.CrossRefPubMed

50.

Foley, F. (2011). Assessment and treatment of sexual dysfunction in multiple sclerosis. In B. Giesser (Ed.), Primer in multiple sclerosis. New York: Oxford University Press.

51.

Griswold, G. A., Halper, F. F., LaRocca, J. N. G., Zemon, V. (2003). Multiple sclerosis and sexuality: A survey of MS health professionals’ comfort, training, and inquiry about sexual dysfunction. Internatonal Journal of MS Care, 5(2), 37–51.CrossRef

52.

Gromisch, E. S., Schairer, L. C., Pasternak, E., Kim, S. H., & Foley, F. W. (2016). Assessment and treatment of psychiatric distress, sexual dysfunction, sleep disturbances, and pain in multiple sclerosis: A survey of members of the consortium of multiple sclerosis centers. International Journal of MS Care, 18(6), 291–297. https://doi.org/10.7224/1537-2073.2016-007.CrossRefPubMedPubMedCentral

53.

Lew-Starowicz, M., & Rola, R. (2014). Sexual dysfunctions and sexual quality of life in men with multiple sclerosis. The Journal of Sexual Medicine, 11(5), 1294–1301. https://doi.org/10.1111/jsm.12474.CrossRefPubMed

54.

Fragala, E., Privitera, S., Giardina, R., Di Rosa, A., Russo, G. I., Favilla, V., et al. (2014). Determinants of sexual impairment in multiple sclerosis in male and female patients with lower urinary tract dysfunction: Results from an Italian cross-sectional study. The Journal of Sexual Medicine, 11(10), 2406–2413. https://doi.org/10.1111/jsm.12635.CrossRefPubMed

55.

Culpepper, W. J., Wallin, M. T., Magder, L. S., Perencevich, E., Royal, W., Bradham, D. D., et al. (2015). VHA multiple sclerosis surveillance registry and its similarities to other contemporary multiple sclerosis cohorts. Journal of Rehabilitation Research & Development (JRRD), 52(3), 263–272. https://doi.org/10.1682/JRRD.2014.07.0172.CrossRef

56.

Fox, R. J., Bacon, T. E., Chamot, E., Salter, A. R., Cutter, G. R., Kalina, J. T., et al. (2015). Prevalence of multiple sclerosis symptoms across lifespan: Data from the NARCOMS Registry. Neurodegenerative Disease Management, 5(6 Suppl), 3–10. https://doi.org/10.2217/nmt.15.55.CrossRefPubMed

Titel: Sex differences in predictors of illness intrusiveness in persons with multiple sclerosis
Auteurs: Lindsay O. Neto
Elizabeth S. Gromisch
Jessica Sloan
Tuula Tyry
Frederick W. Foley
Publicatiedatum: 17-10-2018
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 2/2019
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-018-2023-0

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 2/2019

The paradox of self-rated health following joint replacement surgery

Hearing loss and quality of life in survivors of paediatric CNS tumours and other cancers

Hemoglobin F as a predictor of health-related quality of life in children with sickle cell anemia

Determinants of satisfaction with life and self-esteem in women with breast cancer

Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiency

Health-related quality of life (HRQoL) in beta-thalassemia major (β-TM) patients assessed by 36-item short form health survey (SF-36): a meta-analysis